APA (7th ed.) Citation

Nykanen, A., Sandelin, H., Krebs, R., Keranen, M., Tuuminen, R., Karpanen, T., . . . Lemstrom, K. (2009). 454: Targeting Lymphatic Vessel CCL21 Production by VEGFR-3 Inhibition Prevents Cardiac Allograft Rejection and Arteriosclerosis. Journal of Heart & Lung Transplantation, 28(2), S223. https://doi.org/10.1016/j.healun.2008.11.461

Chicago Style (17th ed.) Citation

Nykanen, A.I, et al. "454: Targeting Lymphatic Vessel CCL21 Production by VEGFR-3 Inhibition Prevents Cardiac Allograft Rejection and Arteriosclerosis." Journal of Heart & Lung Transplantation 28, no. 2 (2009): S223. https://doi.org/10.1016/j.healun.2008.11.461.

MLA (9th ed.) Citation

Nykanen, A.I, et al. "454: Targeting Lymphatic Vessel CCL21 Production by VEGFR-3 Inhibition Prevents Cardiac Allograft Rejection and Arteriosclerosis." Journal of Heart & Lung Transplantation, vol. 28, no. 2, 2009, p. S223, https://doi.org/10.1016/j.healun.2008.11.461.